Enda Kenny
Plus aucun poste en cours
Profil
Enda Kenny served as Chief Executive Officer for Rose Pharma A, Diabetica Ltd., and Chiroxia Ltd.
He was also a Director for Millenium Biologix Corp.
and Osteologix Holdings Plc.
Kenny held the position of Principal at Inamed Corp.
and Delta Biotechnology Ltd.
He served as Chief Operating Officer for OrthoMimetics Ltd.
Additionally, he was Vice President-Global Regulatory Affairs at Stryker Biotech LLC from 1996 to 2004.
Kenny earned an undergraduate degree from University College Dublin in 1980 and a doctorate degree from Imperial College London in 1984.
Anciens postes connus de Enda Kenny
| Sociétés | Poste | Fin |
|---|---|---|
| OSTEOLOGIX HOLDINGS PLC | Directeur/Membre du Conseil | 13/07/2012 |
Rose Pharma A/S
 Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Rose Pharma A/S provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome. It develops treatments for irritable bowel syndrome (IBS) and functional dyspepsia, and disorders. The firm focuses on the medical applications of gastrointestinal hormones. The company was founded in 2003 and is headquartered in Roskilde, Denmark. | President | 27/06/2012 |
Millenium Biologix Corp.
 Millenium Biologix Corp. BiotechnologyHealth Technology Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON. | Directeur/Membre du Conseil | 08/05/2007 |
Stryker Biotech LLC
 Stryker Biotech LLC Medical SpecialtiesHealth Technology Part of Stryker Corp., Stryker Biotech LLC develops, manufactures and markets surgical and medical products. The company is based in Hopkinton, MA. | Conseiller Juridique Général | 01/01/2004 |
Delta Biotechnology Ltd.
 Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Corporate Officer/Principal | - |
Formation de Enda Kenny
| Imperial College London | Doctorate Degree |
| University College Dublin | Undergraduate Degree |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Entreprise privées | 9 |
|---|---|
Inamed Corp.
 Inamed Corp. Medical SpecialtiesHealth Technology Inamed Corp. developed and manufactured breast implants, wrinkle prevention & obesity solutions. Its products were available through its two business divisions: INAMED Aesthetics, and INAMED Health. The company offered breast implants for augmentation, reconstruction surgeries, invasive surgeries for sustained weight loss and other dermal products to correct facial wrinkles. INAMED was headquartered in Santa Barbara, CA. | Health Technology |
Millenium Biologix Corp.
Millenium Biologix Corp. BiotechnologyHealth Technology Millenium Biologix Corp. is focused on the development and commercialization of next generation, skeletal tissue regeneration products and implantable medical devices, initially targeted for orthopedic uses. These products, used alone or in combination configurations, promote the repair and natural healing of human bone and other skeletal tissues such as cartilage. Millenium's strength in developing leading treatments for regenerative medicine is based on its successful integration of three core competencies in advanced biomaterials, biologics and engineering. Its core business activities are focused on tissue engineering products, and on orthobiologicals. It was founded on April 1, 1998 and is headquartered in Kingston, ON. | Health Technology |
Delta Biotechnology Ltd.
Delta Biotechnology Ltd. Pharmaceuticals: OtherHealth Technology Part of Novonesis A/S, Delta Biotechnology Ltd. is a British company that produces and markets a range of valuable proteins from yeast using low-cost manufacturing technologies. The company is based in Windlesham, UK. Delta Biotechnology was acquired by Novozymes A/S on July 06, 2006. | Health Technology |
Rose Pharma A/S
Rose Pharma A/S Pharmaceuticals: MajorHealth Technology Rose Pharma A/S provides pharmaceutical products for treatment of pain in connection with irritable bowel syndrome. It develops treatments for irritable bowel syndrome (IBS) and functional dyspepsia, and disorders. The firm focuses on the medical applications of gastrointestinal hormones. The company was founded in 2003 and is headquartered in Roskilde, Denmark. | Health Technology |
Osteologix Holdings Plc
 Osteologix Holdings Plc Pharmaceuticals: OtherHealth Technology Osteologix Holdings Plc engaged in the development of innovative pharmaceuticals for the treatment and prevention of bone and joint tissues diseases. The company was founded in October 2004 and was headquartered in Dublin, Ireland. | Health Technology |
OrthoMimetics Ltd.
 OrthoMimetics Ltd. Medical SpecialtiesHealth Technology Orthomimetics brings a new dimension to the treatment of joints damaged through sport or other orthopaedic trauma. Its heritage is a trans-Atlantic collaboration between two world-leading academic institutions, the University of Cambridge and the Massachusetts Institute of Technology (MIT), who have each contributed 30 years of experience to the repair of bone and soft tissues respectively. The harnessing of their expertise into viable therapeutic medical products is the foundation of Orthomimetics. | Health Technology |
Diabetica Ltd.
 Diabetica Ltd. Pharmaceuticals: MajorHealth Technology Diabetica Ltd. develops drugs to treat diabetes. Its primary business is the development of novel therapeutics, diagnostic and other innovative technologies in the areas of type 2 diabetes, obesity and metabolic syndrome. The company was founded in September 2004 by Peter Flatt, Neville McClenaghan and Finbarr O'Harte and is headquartered in Coleraine, the United Kingdom. | Health Technology |
Stryker Biotech LLC
Stryker Biotech LLC Medical SpecialtiesHealth Technology Part of Stryker Corp., Stryker Biotech LLC develops, manufactures and markets surgical and medical products. The company is based in Hopkinton, MA. | Health Technology |
Chiroxia Ltd.
 Chiroxia Ltd. Miscellaneous Commercial ServicesCommercial Services Chiroxia Ltd. is an Irish private company located in Dublin. The firm provides legal services. | Commercial Services |
